Systemic sclerosis: a prototypic multisystem fibrotic disorder, Journal of Clinical Investigation, vol.117, issue.3, pp.557-567, 2007. ,
DOI : 10.1172/JCI31139
Review: Evidence That Systemic Sclerosis Is a Vascular Disease, Arthritis & Rheumatism, vol.170, issue.Suppl 3, pp.1953-1962, 2013. ,
DOI : 10.1002/art.37988
Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis, Journal of Cellular and Molecular Medicine, vol.120, issue.6a, pp.1241-1254, 2010. ,
DOI : 10.1111/j.1582-4934.2010.01027.x
Egfl7, a novel epidermal growth factor-domain gene expressed in endothelial cells, Developmental Dynamics, vol.21, issue.2, pp.316-324, 2004. ,
DOI : 10.1002/dvdy.20063
EGFL7: a unique angiogenic signaling factor in vascular development and disease, Blood, vol.119, issue.6, pp.1345-1352, 2012. ,
DOI : 10.1182/blood-2011-10-322446
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation, Nature, vol.428, issue.6984, pp.754-758, 2004. ,
DOI : 10.1038/nature02416
Ye W: EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution, pp.2913-2923, 2007. ,
EGFL7 Is a Chemoattractant for Endothelial Cells and Is Up-Regulated in Angiogenesis and Arterial Injury, The American Journal of Pathology, vol.167, issue.1, pp.275-284, 2005. ,
DOI : 10.1016/S0002-9440(10)62972-0
Epidermal Growth Factor-Like Domain 7 Suppresses Intercellular Adhesion Molecule 1 Expression in Response to Hypoxia/Reoxygenation Injury in Human Coronary Artery Endothelial Cells, Circulation, vol.122, issue.11_suppl_1, pp.156-161, 2010. ,
DOI : 10.1161/CIRCULATIONAHA.109.927715
Epidermal Growth Factor-Like Domain 7 Is a Novel Inhibitor of Neutrophil Adhesion to Coronary Artery Endothelial Cells Injured by Calcineurin Inhibition, Circulation, vol.124, issue.11_suppl_1, pp.197-203, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.110.011734
Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis, J Rheumatol, vol.15, pp.202-205, 1988. ,
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage, Annals of the Rheumatic Diseases, vol.71, issue.6, pp.1064-1072, 2012. ,
DOI : 10.1136/annrheumdis-2011-200837
Differential expression of junctional adhesion molecules in different stages of systemic sclerosis, Arthritis & Rheumatism, vol.185, issue.1, pp.247-257, 2013. ,
DOI : 10.1002/art.37712
Evidence for progressive reduction and loss of telocytes in the dermal cellular network of systemic sclerosis, Journal of Cellular and Molecular Medicine, vol.103, issue.4, pp.482-496, 2013. ,
DOI : 10.1111/jcmm.12028
Angiogenesis in systemic sclerosis: Impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions, Arthritis & Rheumatism, vol.27, issue.3, pp.3550-3561, 2008. ,
DOI : 10.1002/art.23968
Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells, Arthritis & Rheumatism, vol.18, issue.Suppl 4, pp.3552-3562, 2011. ,
DOI : 10.1002/art.30536
Impaired angiogenesis and altered Notch signaling in mice overexpressing endothelial Egfl7, Blood, vol.116, issue.26, pp.6133-6143, 2010. ,
DOI : 10.1182/blood-2010-03-274860
EGFL7 meets miRNA-126: an angiogenesis alliance, Journal of Angiogenesis Research, vol.2, issue.1, p.9, 2010. ,
DOI : 10.1186/2040-2384-2-9
Hypoxia. Hypoxia in the pathogenesis of systemic sclerosis, Arthritis Research & Therapy, vol.11, issue.2, p.220, 2009. ,
DOI : 10.1186/ar2598